Von Willebrand factor in polymyalgia rheumatica and giant cell arteritis.
Patients with giant cell arteritis (GCA) and with polymyalgia rheumatica (PMR) have increased plasma levels of von Willebrand factor (vWF) even during corticosteroid therapy. The association between vWF, subclinical inflammation and cardiovascular complications in GCA/PMR remains to be investigated.
Uddhammar
A C
AC
Department of Rheumatology, Umed University Hospital, Sweden. Agneta.Uddhammar.us@vll.se
D013700:Giant Cell Arteritis / Q000378:metabolism*; D006801:Humans; D011111:Polymyalgia Rheumatica / Q000378:metabolism*; D014841:von Willebrand Factor / Q000378:metabolism*
D014841:von Willebrand Factor